Weight loss and bronchopulmonary dysplasia in very low birth weight infants

Our objective was to evaluate the extent of weight loss in very low birth weight (VLBW) preterm infants and to discover how weight loss and other variables correlate with bronchopulmonary dysplasia (BPD). We conducted an observational study of 387 VLBW preterms, gestational age (GA) < 33 weeks, in a single institution over a period of 5 years. The mean weight loss of AGA infants was significantly greater than that of SGA infants. In AGA infants, GA, z-score, weight loss, and male sex were found to correlate with BPD. After adjustments were made for GA and birth weight, each 10% loss of body weight increased the risk for developing BPD by a factor of 2.7. We concluded that excessive weight loss does not prevent BPD in VLBW preterms and presumably should be prevented. Controlled fluid restriction resulting in milder weight loss is probably the right choice.     

极低出生体质量儿支气管肺发育不良的临床高危因素分析

目的 探讨极低出生体质量儿发生支气管肺发育不良(bronchopulmonary dysplasia,BPD)的临床高危因素.方法 回顾性分析2006年9月至2009年9月我院NICU收治的49例极低出生体质量儿的临床资料,分为BPD组(n=15)和非BPD组(n=34),分析BPD发生的可能危险因素.结果与非BPD组相比,BPD组患儿在胎龄[(29.30±1.48)周vs(30.54±1.60)周]、院内获得性感染(9例vs 10例)、宫内感染(9例vs 8例)、持续气道正压通气时间[(12.47±5.83)d vs(4.24±4.19)d]、高浓度氧疗时间[(1.47±1.41)dvs(0.18±0.63)d]、动脉导管未闭(5例vs 1例)等方面比较,差异有统计学意义(P均＜0.05).Logistic回归分析结果显示持续气道正压通气时间以及宫内感染是极低出生体质量儿发生BPD的高危因素(P＜0.05).结论 预防宫内感染可降低BPD的发生率和严重程度,长时间的持续气道正压通气可能预示早期BPD的发生.     

Cognitive performance at school age of very low birth weight infants with bronchopulmonary dysplasia

The hypothesis was that bronchopulmonary dysplasia (BPD) adversely affects cognitive performance at school age. This prospective cohort study examined three groups of children at 8 to 10 years of age. Group 1 (n = 311) consisted of very low birth weight (VLBW) infants without BPD and Group 2 (n = 95) consisted of VLBW infants with BPD. Group 3 (n = 188) consisted of term infants without BPD. Regression analysis determined the effect of BPD on eight performance measures while controlling for possible confounding variables. Children in Group 3 had the best performance and children in Group 2 had the poorest performance on all measures. These differences were significant (p = .0001) for the Full Scale IQ, Performance IQ, and reading and math grades and ages. Children in Groups 3 and 1 performed better than children in Group 2 for the Verbal IQ (p = .0001) and the Developmental Test of Visual-Motor Integration (p = .0012), but for these two measures there was no significant difference between children in Groups 3 and 1. Thus, poorer performance was found in VLBW infants with a history of BPD.     

Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants.

Frequency and perinatal risk factors in bronchopulmonary dysplasia (BPD) were retrospectively evaluated in a cohort of 242 infants with birth weights less than 1501 g born in one hospital in 1990-1994. At 28 days' postnatal age, 30.7% (59/192) of the infants alive received oxygen supplementation and showed typical radiological changes in chest X-rays. At 36 weeks' corrected gestation, 13.0% (24/184) of the survivors fulfilled these criteria. In multivariate analysis, low birth weight and gestational age, male sex, packed red cell infusions and long duration of ventilator therapy were correlated with an increased risk of BPD at 28 days' postnatal age. Only 49% of the infants with BPD had had respiratory distress syndrome, and 49% of them recovered from BPD by 36 weeks' corrected gestational age. Preeclampsia, low birth weight, rapid birth weight recovery, packed red cell infusions, long duration of ventilator therapy, patent ductus arteriosus and hyperoxia were associated with BPD beyond 36 weeks' corrected gestation. No infant born small for gestational age recovered from BPD before 36 weeks' corrected gestation. The frequency of BPD at 28 days' postnatal age seems to be increasing, but half of the patients recover before term. Factors other than respiratory distress syndrome, especially small birth weight, early weight gain and possibly intrauterine growth retardation are becoming more important risk factors of BPD beyond 36 weeks' corrected gestation.     

Population-based study of bronchopulmonary dysplasia in very low birth weight infants in Switzerland

In Switzerland, data are collected prospectively by collaborators from all nine neonatal intensive care units and their affiliated paediatric units caring for neonates, to determine survival and (pulmonary) outcome of infants with birth weights ranging from 501 to 1500 g. To assess the pulmonary outcome of very low birth weight (VLBW) infants in Switzerland in 1996 and 2000, factors associated with bronchopulmonary dysplasia (BPD) were identified and compared with pulmonary outcomes from the Vermont Oxford Network data. BPD was defined as a requirement for supplemental oxygen at 36 weeks postmenstrual age. Complete data were available for 600 and 636 VLBW infants in 1996 and in 2000, respectively. Mortality rates in Switzerland were significantly higher (1996: 19.2%, 2000: 20.8%) than in the Vermont Oxford Network (1996: 14%, 2000: 14%). Expressed as percentage of infants still hospitalised at 36 weeks postmenstrual age, 16.7% and 13.2% of Swiss VLBW infants were diagnosed with BPD in 1996 and 2000, respectively. These rates were significantly lower than in the Vermont Oxford Network (1996: 28%, 2000: 35%). Infants exposed to factors previously shown to be associated with BPD were investigated: in Switzerland, infants with a history of surfactant replacement therapy and/or mechanical ventilation had a significantly higher rate of BPD in both cohorts. Infants with postnatal transport, sepsis proven by positive blood culture and patent ductus arteriosus had a higher BPD rate only in the 1996 cohort. Between 1996 and 2000, mortality rates and incidence of BPD in VLBW infants remained unchanged in Switzerland. BPD rates in Switzerland are lower than those found in the Vermont Oxford Network whereas a mortality rate comparison displays an inverted picture. We suspect that these effects are interrelated and may be due in part to a selective approach of Swiss neonatologists to resuscitation of infants in the smallest birth weight stratum. Conclusion:The factors listed above have apparently become less important in the context of bronchopulmonary dysplasia and other influences, including prenatal conditions, will need to be investigated.     

Bronchopulmonary dysplasia in very low birth weight infants

Objective  The developments in newborn care have enabled many more very low birth weight premature infants to live. The aim of our study was to determine the risk factors for bronchopulmonary dysplasia (BPD) development by evaluating mild and moderate/severe BPD in extramural neonates with a birth weight <1501 g. Methods  A case-control study was conducted between January 1, 2004- December 31, 2006 at the Dr. Sami Ulus Children’s Hospital Neonatal Intensive Care Unit. Patients with BPD and without BPD were compared. Bronchopulmonary dysplasia was diagnosed and classified according to the Bancalari criteria. One-hundred and six (106) extramural premature infants with a birth weight <1501 g and admitted to the Neonatal Unit in the first three days of life and survived for more than 28 postnatal days were included. Patients with multiple congenital anomalies and complex cardiac pathologies were excluded. The maternal and neonatal risk factors, clinical features, mechanical ventilation treatment were compared. The principal risk factors for BPD development were analyzed and followed by logistic regression test. Results  The diagnosis was mild BPD in 27 of the 106 patients and moderate/severe BPD in 29. The incidence of BPD was 52.8%. Fifty of 106 patients had no BPD. Analysis of risk factors revealed that gestational age ≤28 weeks (p=0.019), birth weight ≤1000 g (p=0.007), hypothermia (p=0.003), acidosis (p=0.003) and hypotension (p=0.005) at admission, respiratory distress syndrome (RDS) ( p<0.001), mechanical ventilation therapy (p<0.001), surfactant therapy (p=0.005), higher amount of mean fluid therapy on 7^th days (p=0.008), nosocomial infection (p<0.001), higher amount of mean packed red cell transfusions (p<0.001) and more than two packed red cell transfusions (p=0.033) were risk factors associated with the development of BPD. Multivariant logistic regression analysis showed acidosis at admission (OR 5.12, 95%CI 1.17–22.27, p=0.029), surfactant treatment (OR 7.53, 95%CI 2.14–26.45, p=0.002), nosocomial infections (OR 4.66, 95%CI 1.27–17.12, p=0.02) and PDA (OR 9.60, 95%CI 2.23–41.22, p=0.002) were risk factors increasing the severity of BPD. Conclusion  The most important risk factors for BPD development in our study were RDS and nosocomial infections while the presence of acidosis at admission, surfactant administration, nosocomial infections and the presence of PDA were the most important risk factors regarding BPD severity. Presence of acidosis at admission as a risk factor emphasized the importance of suitable transport conditions for premature infants.     

极低出生体重儿支气管肺发育不良潮气呼吸肺功能临床观察

目的 研究极低出生体重儿支气管肺发育不良(bronchopulmonary dysplasi,BPD)潮气呼吸肺功能的改变.方法 选取在温州市儿童医院住院的262例极低出生体重儿作为研究对象,在出院前1周内和纠正胎龄6~8个月时做潮气呼吸肺功能检测.根据临床诊断,分为BPD组(65例)和非BPD组(197例),BPD组根据严重程度分为轻度BPD组(31例)、中度BPD组(20例)和重度BPD组(14例),比较不同组患儿的肺功能指标.结果 出院前1周内测量潮气呼吸肺功能显示,BPD组患儿呼吸频率较非BPD组均增快(P均＜0.05);呼气峰流速,75%、50%、25%潮气量时的呼气流速比较,均为重度BPD组高于其余组(P均＜0.05),轻度BPD组低于非BPD组(P均＜0.05);达峰时间比、达峰容积比BPD组较非BPD组均降低,BPD程度越严重,下降越明显(P均＜0.05);各组间潮气量比较差异无统计学意义(P＞0.05).矫正胎龄6~8个月时行潮气呼吸肺功能检查,呼气峰流速,75%、50%、25%潮气量时的呼气流速比较,提示重度BPD组仍较其余组均高(P均＜0.05),达峰时间比、达峰容积比仍低于其余组(P均＜0.05),而其余各组间比较各指标差异均无统计学意义(P＞0.05).结论 出院前1周内BPD患儿有不同程度的肺功能损伤,但随日龄增大(矫正胎龄6~8个月时),部分肺功能指标逐渐改善,但早期重度小气道阻塞性病变仍较严重,因此,积极预防、治疗BPD对呼吸道疾病的防治有重要意义.     

极低出生体重儿支气管肺发育不良及其危险因素分析

目的 探讨极低出生体重儿(VLBWI)支气管肺发育不良(BPD)的发生率和高危因素.方法 回顾性分析我院新生儿重症监护室在2006年8月至2009年2月期间,住院28 d以上VLBWI 122例临床资料,以BPD发生与否分组,采用SPSS 10.0统计软件包进行BPD危险因素分析.结果 25例发生BPD,发生率20.5%,在胎龄<28周的超未成熟儿中BPD发生率70%.BPD主要发生在胎龄<30周、出生体质量<1250 g的早产儿.通过16个单因素分析发现,胎龄、出生体质量、窒息、机械通气、持续气道正压通气、持续气道正压通气时间、呼吸衰竭、新生儿呼吸窘迫综合征、肺表面活性物质治疗、重症肺炎、医院感染等11个因素有统计学意义,两组吸氧时间分别为(41.8±15.2)d和(5.0±9.8)d.通过对胎龄、出生体质量、窒息、机械通气、持续气道正压通气、持续气道正压通气时间、呼吸衰竭、新生儿呼吸窘迫综合征、重症肺炎、医院感染等10个发病因素进行Logistic回归分析,发现胎龄(OR 0.875,95%CI 0.790～0.968,P=0.001)和重症肺炎(OR 155.302,95%CI 8.944～2696.473,P=0.01)是BPD的最危险因素,具有统计学意义.结论 胎龄小和重症肺炎是BPD的高危因素.     

Hypoxic airway constriction in infants of very low birth weight recovering from moderate to severe bronchopulmonary dysplasia

We hypothesized that infants recovering from severe bronchopulmonary dysplasia have airway constriction that is, at least in part, related to borderline hypoxia. If this hypothesis were correct, pulmonary resistance should decrease with the administration of oxygen. To test this hypothesis, we studied 10 infants recovering from severe bronchopulmonary dysplasia (study weight 2490 +/- 275 gm; birth weight 1010 +/- 89 gm; postnatal age 73 +/- 7 days; postconceptional age 38.5 +/- 1.6 weeks) and 10 matched control infants (study weight 2430 +/- 179 gm; birth weight 2320 +/- 195 gm; postnatal age 25 +/- 4 days; postconceptional age 37.5 +/- 0.8 weeks). Resistance and compliance were measured by means of a mask with a flowmeter and an esophageal balloon (with the PEDS computer program). Measurements in both groups were made in quiet sleep, without sedation, during the inhalation of room air and during the fifth minute of oxygen inhalation. We found that (1) total pulmonary resistance, significantly higher in infants with bronchopulmonary dysplasia than in control infants, decreased from 206.1 +/- 47 cm H2O.L-1.sec-1 during inhalation of room air to 106.5 +/- 20.9 during inhalation of 100% oxygen (p less than 0.05) and (2) pulmonary dynamic compliance, lower in infants with bronchopulmonary dysplasia than in control infants, increased significantly with the administration of 100% oxygen. The results suggest that infants with bronchopulmonary dysplasia have airway constriction and that this is alleviated by inhalation of oxygen.     

Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia.

We performed a randomized, double-blind, controlled trial to determine whether vitamin A supplementation in a group of very low birth weight infants would reduce the incidence of bronchopulmonary dysplasia. Forty-nine infants (birth weight 700 to 1100 gm) requiring mechanical ventilation and supplemental oxygen at 96 hours age were randomly assigned to receive either 2000 IU retinyl palmitate (n = 27) or saline placebo (n = 22) intramuscularly every other day for up to 14 doses. There were no differences between treatment groups in the incidences of bronchopulmonary dysplasia at 31 days of postnatal age (vitamin A group 48%, placebo group 55%; p = 0.776), supplemental oxygen requirement at 34 weeks of postconceptional age, or other complications of prematurity. The vitamin A group had higher mean plasma vitamin A concentrations than the placebo group, but mean plasma vitamin A concentrations were greater than 20 micrograms/dl (suggesting sufficiency) in both groups after the first study week. By study day 28, only one fourth of the infants in either group had plasma vitamin A concentrations less than 20 micrograms/dl. In contrast to an earlier report, we found no change in the incidence of BPD with vitamin A supplementation. Our findings may reflect a low baseline incidence of vitamin A deficiency in the study population and recent changes in the respiratory care of very low birth weight infants. The latter may have lessened the potential impact of vitamin A deficiency on lung disease.     

肺表面活性物质联合布地奈德预防极低出生体重儿支气管肺发育不良的疗效观察

目的探讨肺表面活性物质(PS)联合布地奈德气管内滴入预防极低出生体重早产儿支气管肺发育不良(BPD)的临床疗效。方法选取胎龄32周的患有宫内感染的呼吸窘迫综合征(NRDS)(Ⅲ或Ⅳ级)的极低出生体重儿30例,随机分成PS+布地奈德组(15例)和PS组(15例)。比较两组血气分析、氧合指数(OI)、呼吸机使用时间、吸氧时间、BPD发生率、纠正胎龄36周时病死率以及其他并发症的发生率。结果 PS+布地奈德组患儿BPD发生率低于PS组,呼吸机使用时间和吸氧时间明显短于PS组(P0.05);给药后第2~6天,PS+布地奈德组pH、OI均高于PS组,PaCO——2均低于PS组,且差异均有统计学意义(P0.05);两组间纠正胎龄36周时病死率以及其他并发症差异无统计学意义。结论 PS联合布地奈德气管内滴入能有效降低重度NRDS极低出生体重早产儿BPD的发生率。     

呼吸窘迫综合征极低出生体重儿解脲脲原体感染与支气管肺发育不良的关系

目的 探讨并发新生儿呼吸窘迫综合症（RDS）的极低出生体重儿下呼吸道分泌物解脲脲原体（UU）感染与支气管肺发育不良（BPD）的关系。方法 选取73例诊断为RDS、早期使用机械通气治疗且至少应用1剂肺表面活性物质的极低出生体重儿,采用荧光定量聚合酶链反应法检测气管内吸出物UU核酸,分为UU感染组（n=21）和非感染组（n=52）,比较两组临床特点及BPD的发生率。结果 UU感染组阴道产百分率及反复院内肺部感染、胎膜早破发生率均高于非感染组;胎膜早破持续时间长于非UU感染组;且吸氧时间及住院时间均长于非UU感染组。UU感染组生后3 h内血浆免疫球蛋白IgM、白细胞计数、中性粒细胞绝对值显著高于非UU感染组。73例患儿中,发生BPD 45例,其中UU感染组BPD发生率（90%,19/21）显著高于非UU感染组（50%,26/52）,差异有统计学意义（P结论 下呼吸道UU感染可增加RDS 极低出生体重儿BPD的发生率。     

极低及超低出生体重儿的预后因素分析

目的 分析极低及超低出生体重儿（出生体重≤ 1 200 g）的临床资料,为其预后及临床干预提供预警指标。方法 回顾性分析108 例极低及超低出生体重儿的母孕期病史、新生儿出生时情况、诊治经过及预后,采用非条件logistic 回归分析筛选预后的影响因素。结果 108 例极低及超低出生体重儿,出生体重范围在结论 极低及超低出生体重儿的病死率较高,且随着日龄的增加,影响早产儿生存的预后因素不同,临床上应针对这些因素制定合理的管理方案,提高早产儿生存率。     

极低/超低出生体重儿甲状腺功能减退的临床分析

目的 分析极低/超低出生体重（VLBW/ELBW）患儿甲状腺功能减退的危险因素和治疗情况。方法 选择2018年9月至2019年12月诊断为甲状腺功能减退的VLBW/ELBW患儿为病例组（n=29）,按照1：3比例匹配甲状腺功能正常的VLBW/ELBW患儿作为对照组（n=87）,比较两组患儿的临床特征,分析甲状腺功能与出生胎龄、出生体重的相关性及甲状腺功能减退的危险因素。结果 符合纳入标准的VLBW/ELBW患儿共162例,其中病例组29例,甲状腺功能减退发生率为17.9%。出生体重越低,甲状腺功能减退发生率越高（P < 0.05）;三碘甲状腺原氨酸（T3）、游离三碘甲状腺原氨酸（FT3）与出生胎龄呈正相关（P < 0.05）,T3、游离甲状腺素（FT4）与出生体重呈正相关（P < 0.05）。小于胎龄儿、多胎、孕母≥35岁、使用多巴胺是发生甲状腺功能减退的独立危险因素（P < 0.05）。病例组中16例患儿给予左旋甲状腺素（每日5~10 μg/kg）治疗,甲状腺功能在治疗2周后恢复正常。结论 VLBW/ELBW患儿甲状腺功能减退的发生率较高,小于胎龄儿、多胎、孕母高龄、应用多巴胺是其发生甲状腺功能减退的危险因素,应用左旋甲状腺素治疗的患儿需定期随访,以保证用药剂量适宜。